Perrigo Business Finance Contracts & Agreements

35 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Supplemental Indenture No. 7 to Indenture for €350,000,000 5.375% Senior Notes due 2032 among Perrigo Finance Unlimited Company, Perrigo Company plc, Subsidiary Guarantors, and...
Indenture Agreements
Perrigo
Pharmaceuticals
NY
2024
Supplemental Indenture No. 6 to Indenture Dated December 2, 2014 for $715,000,000 6.125% Senior Notes due 2032 among Perrigo Finance Unlimited Company, Perrigo Company plc,...
Indenture Agreements
Perrigo
Pharmaceuticals
NY
2024
Underwriting Agreement for Perrigo Finance Unlimited Company $715,000,000 6.125% and €350,000,000 5.375% Senior Notes Due 2032
Underwriting Agreements
Perrigo
Pharmaceuticals
NY
2024
Purchase and Sale Agreement between Perrigo Company plc and Esteve Healthcare, S.L. (July 3, 2024)
Purchase Agreements
Perrigo
Pharmaceuticals
2024
Perrigo Company plc Service-Based Restricted Stock Unit Award Agreement under 2019 Long-Term Incentive Plan
Bonus & Incentive Agreements
Perrigo
Pharmaceuticals
MI
2023
Amendment No. 3 to Revolving Credit Agreement among Perrigo Finance Unlimited Company, Perrigo Company PLC, Lenders, and JPMorgan Chase Bank, N.A.
Modification Agreements
Perrigo
Pharmaceuticals
NY
2021
Amendment No. 2 and Waiver to Revolving Credit Agreement among Perrigo Finance Unlimited Company, Perrigo Company PLC, JPMorgan Chase Bank, N.A., and Lenders
Modification Agreements
Perrigo
Pharmaceuticals
NY
2021
Amendment to Stock and Asset Purchase Agreement between Perrigo Company plc and Padagis LLC (July 6, 2021)
Modification Agreements
Perrigo
Pharmaceuticals
2021
Supplemental Waiver and Release Agreement Between Perrigo Company plc and Ronald Winowiecki (July 1, 2019)
Separation Agreements
Perrigo
Pharmaceuticals
2019
Waiver and Release Agreement by and between Perrigo Company plc and Ronald Winowiecki effective as of April 17, 2019
Release Agreements
Perrigo
Pharmaceuticals
MI
2019
Supplemental Indenture No. 2 to Indenture for Perrigo Finance Unlimited Company Senior Notes (2021 & 2026)
Indenture Agreements
Perrigo
Pharmaceuticals
NY
2016
Share Purchase Agreement for Omega Pharma Invest NV Between Alychlo NV, Holdco I BE NV, and Perrigo Company PLC (November 6, 2014)
Purchase Agreements
Perrigo
Pharmaceuticals
NY
2014
Indenture Agreement for Perrigo Company Limited Senior Notes (2016, 2018, 2023, 2043) with Wells Fargo Bank, N.A. as Trustee
Indenture Agreements
Perrigo
Pharmaceuticals
NY
2013
Fourth Supplemental Indenture by and among Perrigo Company plc, Perrigo Finance Unlimited Company, the Guarantor Subsidiaries named therein, and Wells Fargo Bank, National...
Indenture Agreements
Perrigo
Pharmaceuticals
2022
Third Supplemental Indenture by and among Perrigo Company plc, the Guarantor Subsidiaries named therein, and Wells Fargo Bank, National Association, as Trustee, dated as of May...
Indenture Agreements
Perrigo
Pharmaceuticals
2022
Amendment No. 2 to Term Loan Credit Agreement among Perrigo Finance Unlimited Company, Perrigo Company PLC, Lenders, and JPMorgan Chase Bank, N.A.
Loan Agreements
Perrigo
Pharmaceuticals
NY
2021
Amendment No. 1 and Waiver to Term Loan Credit Agreement among Perrigo Finance Unlimited Company, Perrigo Company PLC, JPMorgan Chase Bank, N.A., and Lenders
Loan Agreements
Perrigo
Pharmaceuticals
NY
2021
Stock and Asset Purchase Agreement between Perrigo Company plc and Vestas Pharma LLC dated March 1, 2021
Purchase Agreements
Perrigo
Pharmaceuticals
DE
2021
Supplemental Indenture No. 3 to Indenture for $750,000,000 3.150% Senior Notes due 2030 among Perrigo Finance Unlimited Company, Perrigo Company plc, and Wells Fargo Bank, N.A.
Indenture Agreements
Perrigo
Pharmaceuticals
NY
2020
Underwriting Agreement for $750,000,000 3.150% Senior Notes due 2030 by Perrigo Finance Unlimited Company and Perrigo Company plc
Underwriting Agreements
Perrigo
Pharmaceuticals
NY
2020
Term Loan Credit Agreement among Perrigo Finance Unlimited Company, Perrigo Company plc, and Lenders (August 15, 2019)
Credit Agreements
Perrigo
Pharmaceuticals
NY
2019
Amendment Agreement to Stock Escrow Agreement among Alychlo NV, Perrigo Company plc, Perrigo Ireland 2 Ltd, and Computershare Inc.
Escrow Agreements
Perrigo
Pharmaceuticals
2018
Term Loan Credit Agreement among Perrigo Finance Unlimited Company, Perrigo Company plc, and Lenders (March 8, 2018)
Credit Agreements
Perrigo
Pharmaceuticals
NY
2018
Revolving Credit Agreement among Perrigo Finance Unlimited Company, Perrigo Company plc, and Lenders (March 8, 2018)
Credit Agreements
Perrigo
Pharmaceuticals
NY
2018
Second Waiver to Note Purchase Agreement between Omega Pharma N.V. and Noteholders
Waiver Agreements
Perrigo
Pharmaceuticals
2016
Waiver to Note Purchase Agreement between Omega Pharma N.V. and Noteholders (May 16, 2016)
Waiver Agreements
Perrigo
Pharmaceuticals
2016
First Amendment and Consent to Note Purchase Agreement between Omega Pharma N.V. and Noteholders
Note Agreements
Perrigo
Pharmaceuticals
2016
Underwriting Agreement for $1.2 Billion Senior Notes Offering by Perrigo Finance Unlimited Company and Perrigo Company plc
Underwriting Agreements
Perrigo
Pharmaceuticals
NY
2016
Revolving Credit Agreement among Perrigo Finance Unlimited Company, Perrigo Company plc, and Lenders (2015)
Credit Agreements
Perrigo
Pharmaceuticals
NY
2015
Omega Pharma Invest NV EUR 200–300 Million 5.125% Fixed Rate Bonds Due 2017 Prospectus
Note Agreements
Perrigo
Pharmaceuticals
2015
Omega Pharma N.V. €135,043,889 5.1045% Guaranteed Senior Notes Due 2023 Note Purchase Agreement
Note Agreements
Perrigo
Pharmaceuticals
NY
2015
Underwriting Agreement between Perrigo Company plc and Underwriters for Sale of Ordinary Shares
Underwriting Agreements
Perrigo
Pharmaceuticals
NY
2014
Second Supplemental Indenture among Perrigo Company plc, Elan Guarantors, and Wells Fargo Bank, N.A. (Trustee)
Indenture Agreements
Perrigo
Pharmaceuticals
2014
First Supplemental Indenture among Perrigo Company plc, Guarantors, and Wells Fargo Bank, N.A. (2013)
Indenture Agreements
Perrigo
Pharmaceuticals
2013
Registration Rights Agreement among Perrigo Company Limited, Leopard Company, Habsont Limited, Barclays Capital Inc., and HSBC Securities (USA) Inc.
Registration Rights Agreements
Perrigo
Pharmaceuticals
NY
2013